Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 22 Jul 2026 for Sagimet Biosciences Inc., €72k.
Filing timeline
BuySaleElizabeth Rozek
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Elizabeth Rozek: trading record in brief
All filings by Elizabeth Rozek on record concern Sagimet Biosciences Inc. In total, 8 filings cover trades dated from 17 November 2023 to 20 July 2026.
Every open-market trade on record is a sale: 4 sales worth €199k. Outside the open market, there are 4 share grants. 2026 to date brings no purchases and 2 sales.
The latest filing, published on 22 July 2026, reports an open-market sale of €72k in Sagimet Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Elizabeth Rozek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
10,545 shares@ US$7.76030.014% mcap36.0% of flowSeries A Common StockSEC:0001193125-26-312394:0
44,000 shares0Series A Common StockSEC:0001104659-26-018196:0
2,622 shares@ US$5.36025.9% of flowSeries A Common StockSEC:0001104659-26-014266:0
9,855 shares0Series A Common StockSEC:0001104659-25-107806:0
10,780 shares@ US$9.134642.4% of flowSeries A Common StockSEC:0001104659-25-070013:0
34,000 shares0Series A Common StockSEC:0001104659-25-010586:0
10,914 shares@ US$3.099715.6% of flowSeries A Common StockSEC:0001104659-24-081891:0
171,420 shares0Series A Common StockSEC:0001104659-23-120377:0
8 of 8 declarations
